GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis India Ltd (BOM:500672) » Definitions » Ending Cash Position

Novartis India (BOM:500672) Ending Cash Position : ₹0 Mil (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Novartis India Ending Cash Position?

Novartis India's Ending Cash Position for the quarter that ended in Mar. 2024 was ₹0 Mil.

Novartis India's annual Ending Cash Position declined from Mar. 2022 (₹1,584 Mil) to Mar. 2023 (₹194 Mil) but then increased from Mar. 2023 (₹194 Mil) to Mar. 2024 (₹450 Mil).


Novartis India Ending Cash Position Historical Data

The historical data trend for Novartis India's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis India Ending Cash Position Chart

Novartis India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 791.20 682.70 1,583.50 194.20 449.60

Novartis India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Novartis India Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Novartis India's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=194.2+255.4
=450

Novartis India's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0


Novartis India Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Novartis India's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis India (BOM:500672) Business Description

Traded in Other Exchanges
N/A
Address
Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company single business segment namely Pharmaceuticals, Its Pharmaceutical business focuses on Bone and Pain, Calcium portfolio, Gynecology, and Neurosciences.

Novartis India (BOM:500672) Headlines

No Headlines